2011-2020年中国东南地区妇科癌症的存活率分析:基于人口的研究
Sufang Deng1, Yan Zhou2, Jie Lin1
1Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Cancer epidemiology
|August 21, 2024
概括
中国福建的妇科癌症存活率有所改善,但仍然低于发达国家. 进一步强调查和治疗对于宫,子宫和卵巢癌的更好的结果至关重要.
科学领域:
- 妇科瘤学 妇科瘤学
- 癌症流行病学 癌症流行病学
- 公共卫生 公共卫生
背景情况:
- 妇科癌症,包括宫癌,子宫癌和卵巢癌,在全球范围内构成重大健康挑战.
- 东南中国,特别是福建省,有着这些恶性瘤的显著负担.
- 了解区域生存趋势对于有针对性的干预至关重要.
研究的目的:
- 分析2011年至2020年期间在福建省诊断出宫,子宫和卵巢癌的女性患者的生存结果.
- 建立该地区妇科恶性瘤预后评估和预防策略的参考.
主要方法:
- 利用了福建省癌症预防和控制系统 (2011-2020年) 中注册的5823名患者的数据.
- 进行了生存分析,根据诊断时的年龄和乡镇分层.
- 使用国际癌症生存标准 (ICSS) 到2022年3月30日计算的相对生存率 (RS) 和年龄标准化的RS.
主要成果:
- 宫癌,子宫癌和卵巢癌的5年相对存活率 (RS) 从2011-2015年增加到2016-2020年 (例如,宫癌的RS从64.3%上升到72.3%).
- 年龄标准化的5年RS也显示了所有三种癌症类型的改善.
- 对于宫癌和卵巢癌,存活率通常随着年龄的增长而下降,而子宫癌存活率在45-54岁年龄组达到顶峰,并在75岁时最低. 城市地区的生存率高于农村地区.
结论:
- 宫癌,子宫癌和卵巢癌的生存率在福建省显示出积极的趋势.
- 尽管情况有所改善,但福建的生存率仍落后于发达国家.
- 建议加强妇科癌症查计划和实施有效的治疗方法,以进一步改善患者的生存率.
相关概念视频
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Comparing the Survival Analysis of Two or More Groups
162
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
162
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Introduction To Survival Analysis
197
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
197
Actuarial Approach
68
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
68


